THE FDA APPROVED A NEW DRUG USED TO TREAT ALZHEIMER’S BACK IN JULY, DESPITE CRITICISM FROM MANY PHYSICIANS THAT THERE WAS NOT ENOUGH PERSUASIVE EVIDENCE TO SUPPORT ITS APPROVAL WITHOUT MORE CLINICAL TRIALS. JOINING US TO DISCUSS IS DR. PETER RABINS, CO-AUTHOR OF “THE 36-HOUR DAY”, THE DEFINITIVE GUIDE TO LIVING WITH (OR CARING FOR) PATIENTS WITH ALZHEIMER’S.